BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19672785)

  • 21. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
    Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
    J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
    Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
    Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Ki-67, cyclin E, and p63 in benign and malignant human pleomorphic adenoma.
    Zhu X; Zhang J; Chen X; Feng X
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 May; 113(5):667-72. PubMed ID: 22668626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collagen type I may influence the expression of E-cadherin and beta-catenin in carcinoma ex-pleomorphic adenoma.
    Araújo VC; Demasi AP; Furuse C; Altemani A; Alves VA; Freitas LL; Araújo NS
    Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):312-8. PubMed ID: 19276972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry.
    Martins C; Fonseca I; Roque L; Pereira T; Ribeiro C; Bullerdiek J; Soares J
    Mod Pathol; 2005 Aug; 18(8):1048-55. PubMed ID: 15920557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxiredoxin I, platelet-derived growth factor A, and platelet-derived growth factor receptor alpha are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation.
    Demasi AP; Furuse C; Soares AB; Altemani A; Araújo VC
    Hum Pathol; 2009 Mar; 40(3):390-7. PubMed ID: 18992915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
    Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
    Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
    Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
    Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence.
    Ramachandran I; Ganapathy V; Gillies E; Fonseca I; Sureban SM; Houchen CW; Reis A; Queimado L
    Cell Death Dis; 2014 May; 5(5):e1246. PubMed ID: 24853424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF-2 is overexpressed in myoepithelial cells of carcinoma ex-pleomorphic adenoma in situ structures.
    Martinez EF; Demasi AP; Miguita L; Altemani A; Araújo NS; Araújo VC
    Oncol Rep; 2010 Jul; 24(1):155-60. PubMed ID: 20514456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma.
    de Lima-Souza RA; Scarini JF; Lavareze L; Emerick C; Crescencio LR; Domingues RR; Paes Leme AF; Mariz BALA; Bastos DC; Machado RA; Tincani AJ; Del Negro A; Chone CT; Kowalski LP; Egal ESA; Altemani A; Mariano FV
    Oral Dis; 2023 Apr; 29(3):1017-1027. PubMed ID: 34902207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytological features of carcinoma ex pleomorphic adenoma of the salivary glands: A diagnostic challenge.
    Okano K; Ishida M; Sandoh K; Fujisawa T; Iwai H; Tsuta K
    Diagn Cytopathol; 2020 Feb; 48(2):149-153. PubMed ID: 31675185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
    Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
    Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleomorphic adenoma and carcinoma ex pleomorphic adenoma: immunohistochemical demonstration of the association between tenascin expression and malignancy.
    Félix A; Rosa JC; Fonseca I; Cidadão A; Soares J
    Histopathology; 2004 Aug; 45(2):187-92. PubMed ID: 15279638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble E-cadherin promotes invasiveness of neoplastic cells in salivary gland carcinoma ex pleomorphic adenoma.
    Chen W; Ye S; Wang X; Qian J; Xia L; Tian Z
    J Oral Pathol Med; 2023 Jan; 52(1):63-71. PubMed ID: 36445289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and amplification of neu oncogene in pleomorphic adenomas of salivary gland.
    Kahn HJ; Hanna W; Auger M; Andrulis I
    Arch Pathol Lab Med; 1992 Jan; 116(1):80-3. PubMed ID: 1346490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    Kimura TC; Scarini JF; Lavareze L; Kowalski LP; Coutinho-Camillo CM; Krepischi ACV; Egal ESA; Altemani A; Mariano FV
    Head Neck; 2024 May; 46(5):985-1000. PubMed ID: 38482546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100P expression in ductal type of carcinoma ex pleomorphic adenoma.
    Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
    Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinoma ex-pleomorphic adenoma of upper lip showing copy number loss of tumor suppressor genes.
    Mariano FV; Rincon D; Gondak RO; Jorge R; Lopes MA; Altemani A; de Almeida OP; Kowalski LP
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jul; 116(1):69-74. PubMed ID: 23510689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism.
    Cavalcante RB; Nonaka CF; Rabenhorst SH; da Costa Miguel MC; Pinto LP; de Souza LB
    Arch Oral Biol; 2017 Jan; 73():48-54. PubMed ID: 27665273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.